Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation
By M. McCallum, A. Walls, John E. Bowen, D. Corti, D. Veesler. 2020
161 citations recorded by the source corpus.
SARS-CoV-2 is the causative agent of the COVID-19 pandemic, with 10 million infections and more than 500,000 fatalities by June 2020. To initiate infection, the SARS-CoV-2 spike (S) glycoprotein promotes attachment to the host cell surface and fusion of the viral and host membranes. Prefusion SARS-CoV-2 S is the main target of neutralizing antibodies and the focus of vaccine design. However, its limited stability and conformational dynamics are limiting factors for developing countermeasures against this virus. We report here the design of a construct corresponding to the prefusion SARS-CoV-2 S ectodomain trimer, covalently stabilized by a disulfide bond in the closed conformation. Structural and antigenicity analyses show we successfully shut S in the closed state without otherwise altering its architecture. We demonstrate that this strategy is applicable to other β-coronaviruses, such as SARS-CoV and MERS-CoV, and might become an important tool for structural biology, serology, vaccine design and immunology studies. The conformational dynamics of SARS-CoV-2 spike are constrained by engineering a disulfide bond that locks the protein in a closed conformation, a strategy that was also applied to SARS-CoV and MERS-CoV.
Subfields: Ecology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Ecology
In Infectious Diseases
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2 (2020, positive): “Several reports of stabilized prefusion SARS-CoV-2 S variants provide promising antigens that can be used to test this hypothesis (Henderson et al., 2020; Hsieh et al., 2020; McCallum et al., 2020; Xiong et al., 2020).”
- mRNA-based therapeutics: powerful and versatile tools to combat diseases (2022, background): “SARS-CoV-2 S protein is intrinsically metastable and can be stabilized in a prefusion conformation by structure-based design.(549,550) Prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.”